RSV Immunization clinical trials at UCSF

1 research study open to eligible people

RSV immunization is a vaccine or medicine that protects people from the respiratory syncytial virus. UCSF is studying community-based ways to increase RSV vaccine use among Latino adults. The study works with local groups to learn what helps people get vaccinated.

Showing trials for

  • Community-Based Measures to Increase RSV Vaccine Use Among Latino Adults

    open to eligible people ages 18 years and up

    In collaboration with community-based organizations, this study will focus on increasing RSV vaccine use among Latinos. The study will determine how effective community health worker counseling and text-message approaches are to (1) increase RSV vaccine use among older adults (Motivate phase) and (2) encourage younger adults to discuss RSV vaccination with their older friends and family members (Activate phase).

    San Francisco, California

Our lead scientists for RSV Immunization research studies include .

Last updated: